# Keith A.A. Fox

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/keith-a-a-fox/

## Facts

| Field | Value |
| --- | --- |
| Citations | 116,065 |
| Field | Acute Myocardial Infarction Research |
| h-index | 145 |
| i10-index | 664 |
| Last Known Institution | University of Edinburgh |
| OpenAlex ID | https://openalex.org/A5039466154 |
| ORCID iD | https://orcid.org/0000-0002-0140-2752 |
| Works | 1,227 |

## Researcher papers

Showing 12 of 29.

- [Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation](https://scholariq.org/papers/rivaroxaban-versus-warfarin-in-nonvalvular-atrial-fibrillation/)
- [Third universal definition of myocardial infarction](https://scholariq.org/papers/third-universal-definition-of-myocardial-infarction-3/)
- [Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events](https://scholariq.org/papers/clopidogrel-and-aspirin-versus-aspirin-alone-for-the-prevention-of/)
- [Third Universal Definition of Myocardial Infarction](https://scholariq.org/papers/third-universal-definition-of-myocardial-infarction/)
- [Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction](https://scholariq.org/papers/universal-definition-of-myocardial-infarction-kristian-thygesen-joseph-s-alpert/)
- [Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-stable-cardiovascular-disease/)
- [w2145813488](https://scholariq.org/papers/w2145813488/)
- [Rivaroxaban in Patients with a Recent Acute Coronary Syndrome](https://scholariq.org/papers/rivaroxaban-in-patients-with-a-recent-acute-coronary-syndrome/)
- [Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)](https://scholariq.org/papers/prediction-of-risk-of-death-and-myocardial-infarction-in-the-six-months-after/)
- [A Validated Prediction Model for All Forms of Acute Coronary Syndrome](https://scholariq.org/papers/a-validated-prediction-model-for-all-forms-of-acute-coronary-syndrome/)
- [Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes](https://scholariq.org/papers/adverse-impact-of-bleeding-on-prognosis-in-patients-with-acute-coronary/)
- [Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes](https://scholariq.org/papers/early-intensive-vs-a-delayed-conservative-simvastatin-strategy-in-patients-with/)

## Researcher topics

- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)

## Researcher university

- [University of Edinburgh](https://scholariq.org/institutions/university-of-edinburgh/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.